Marinus Pharmaceuticals Inc. (MRNS) Tumbled -7.97% or -0.56 To Price $6.47 On Thursday


Marinus Pharmaceuticals Inc. (MRNS) tumbled -7.97% or -0.56 to $6.47. It is about 1.33 million shares traded, which is 174.94% compare to the average total volume 762844. The market cap of MRNS is $262.17 million. The year to date change is -24.28%. The 52 week price range is from $1.8 to $9.87. Price of MRNS have changed -5.00% during last week. It have changed -8.10% over last month, 56.22% over last 3 months, -2.09% over last 6 months N/A

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MRNS is 7.08. It is 9.43% above current price. The 200-day Moving Averages for MRNS is 6.22. It is -3.86% below current price. The 52-week High is 9.87. It is 52.55% from the current price. The 52-week Low is 1.8. It is -72.18% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of MRNS is 4.55 on 2018-07-13. Short % to float is 10.71%. There are some statistics of MRNS. It is has market cap $262.17 million. The share outstanding is 40.52 million. The average volume is 762844. The percent of top 15 Institution holding is 51.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MRNS is -53.77%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MRNS is -47.54%.


Tags:

Share this post